{"schema_version":"1","generated_at":"2026-10-29T07:46:12.217Z","data_as_of":"2026-08-14","url":"https://www.findmykol.com/kol/claudia-ordonez","json_url":"https://www.findmykol.com/kol/claudia-ordonez/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"claudia-ordonez","name":"Claudia Ordonez","credential":"MD","title":"Senior Vice President, Medical Science, CervoMed Inc.","specialty":"Pediatric Pulmonology","specialty_raw":"Pediatric Pulmonology","therapeutic_area":"Respiratory","therapeutic_areas":["Respiratory"],"institution":"CervoMed Inc.","institution_url":"https://www.findmykol.com/institution/cervomed-inc","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1679650303","openalex":"A5105987584"},"summary":"Claudia Ordonez is Senior Vice President, Medical Science, CervoMed Inc. at CervoMed Inc.. ClinicalTrials.gov lists 4 registered studies with this person as an investigator.","overview":{"text":"Claudia L. Ordoñez, MD, is Senior Vice President, Medical Science, CervoMed Inc.. The public record shows 30 publications with 7,625 citations (h-index 19), centered on Cystic Fibrosis. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 2 companies, 3 NIH-funded awards (2000–2007).","bullets":["Top research focus: Cystic Fibrosis","4 registered trials on ClinicalTrials.gov","Open Payments reporting from 2 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Cystic Fibrosis","therapeutic_area":"Respiratory","trials":4,"topics":0,"strength":12},{"label":"Cysts","therapeutic_area":"Oncology","trials":4,"topics":0,"strength":12}],"research_topics":["Cystic Fibrosis"],"works_with":{"total":3,"shown":3,"withheld":0,"rows":[{"name":"Ipsen Bioscience Inc.","trials":0,"payments":9,"mentions":9},{"name":"Flatley Discovery Lab LLC","trials":4,"payments":0,"mentions":4},{"name":"Vertex Pharmaceuticals Incorporated","trials":0,"payments":2,"mentions":2}]}},"scholarship":{"h_index":19,"pubmed_count":0,"latest_activity_year":2025,"source":"works"},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT03527095","title":"A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects","phase":"PHASE1","status":"COMPLETED","role":"Investigator","sponsor":"Flatley Discovery Lab LLC","source_url":"https://clinicaltrials.gov/study/NCT03527095","trial_url":"https://www.findmykol.com/trial/NCT03527095"},{"nct":"NCT03516331","title":"A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects","phase":"PHASE1","status":"COMPLETED","role":"Investigator","sponsor":"Flatley Discovery Lab LLC","source_url":"https://clinicaltrials.gov/study/NCT03516331","trial_url":"https://www.findmykol.com/trial/NCT03516331"},{"nct":"NCT03173573","title":"A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants","phase":"PHASE1","status":"COMPLETED","role":"Investigator","sponsor":"Flatley Discovery Lab LLC","source_url":"https://clinicaltrials.gov/study/NCT03173573","trial_url":"https://www.findmykol.com/trial/NCT03173573"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2024,"last":2025},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Ipsen Bioscience Inc.","program_year":2025,"amount_usd":750,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1679650303"},{"payer":"VERTEX PHARMACEUTICALS INCORPORATED","program_year":2025,"amount_usd":33.06,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1679650303"},{"payer":"Ipsen Bioscience Inc.","program_year":2024,"amount_usd":72625,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1679650303"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1679650303","source":"payments"},"funding":{"award_count":3,"fiscal_years":{"first":2000,"last":2007},"rows_total":21,"shown":3,"withheld":18,"rows":[{"project":"R01FD003432","title":"Phase 2 study of VX-770 in Cystic Fibrosis Subjectswith G551D","fiscal_year":2007,"amount_usd":350000,"organization":"VERTEX PHARMACEUTICALS, INC.","source_url":"https://reporter.nih.gov/quickSearch/R01FD003432"},{"project":"K23HL075502","title":"P aeruginosa virulence in cystic fibrosis lung disease","fiscal_year":2006,"amount_usd":154683,"organization":"BOSTON CHILDREN'S HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/K23HL075502"},{"project":"M01RR002172","title":"ASSESSMENT OF INDUCED SPUTUM AS A TOOL TO EVALUATE ANTI-INFLAMMATORY AGENTS","fiscal_year":2006,"amount_usd":8124,"organization":"BOSTON CHILDREN'S HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/M01RR002172"}],"source":"grants"},"publications":{"total":0,"shown":5,"withheld":25,"matched_by":"OpenAlex author record","recent":[{"title":"Food Insecurity Is Associated With Low Tenofovir Diphosphate in Dried Blood Spots in South African Persons With HIV","year":2023,"journal":"Open Forum Infectious Diseases","source_url":"https://doi.org/10.1093/ofid/ofad360","status":"verified"},{"title":"A Phase 2, Open-Label, Ascending Dose Study of Ker-050 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes","year":2021,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2021-147335","status":"verified"},{"title":"Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation","year":2020,"journal":"UNC Libraries","source_url":"https://doi.org/10.17615/bbpq-c156","status":"verified"},{"title":"Administration of KER-047, a Novel ALK2 Inhibitor, Elicited Robust and Sustained Increases in Serum Iron in Healthy Participants","year":2020,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2020-140323","status":"verified"},{"title":"EPS3.06 Safety, pharmacokinetics and pharmacodynamics of the CFTR corrector FDL169","year":2018,"journal":"Journal of Cystic Fibrosis","source_url":"https://doi.org/10.1016/s1569-1993(18)30251-0","status":"verified"}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/claudia-ordonez-md","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":4,"shown":4,"rows":[{"value":"Fellowship in Pediatric Pulmonology, UCSF (1995-1998)","source_url":"https://www.doximity.com/pub/claudia-ordonez-md","status":"provisional","collected_at":"2026-10-28"},{"value":"Pediatrics Residency, Children's Hospital Oakland (1991-1994)","source_url":"https://www.doximity.com/pub/claudia-ordonez-md","status":"provisional","collected_at":"2026-10-28"},{"value":"M.D., University of California, San Francisco School of Medicine (1991)","source_url":"https://www.doximity.com/pub/claudia-ordonez-md","status":"provisional","collected_at":"2026-10-28"},{"value":"B.A. in Biology, University of Maryland, Baltimore County","source_url":"https://people.equilar.com/bio/person/claudia-ordonez-cervomed-inc/30721614","status":"provisional","collected_at":"2026-10-28"}]},"roles":{"total":1,"shown":1,"rows":[{"value":"Clinical Instructor in Pediatrics, Boston Children's Hospital (historical, CF-focused academic appointment)","source_url":"https://www.doximity.com/pub/claudia-ordonez-md","status":"provisional","collected_at":"2026-10-28"}]},"secondary_affiliations":{"total":3,"shown":3,"rows":[{"value":"Flatley Discovery Lab, Chief Medical Officer (cystic fibrosis drug discovery), 2015-2018","source_url":"https://people.equilar.com/bio/person/claudia-ordonez-cervomed-inc/30721614","status":"provisional","collected_at":"2026-10-28"},{"value":"Boston Children's Hospital (attending physician, cystic fibrosis, 1998-2013)","source_url":"https://people.equilar.com/bio/person/claudia-ordonez-cervomed-inc/30721614","status":"provisional","collected_at":"2026-10-28"},{"value":"Vertex Pharmaceuticals, Senior Medical Director (cystic fibrosis clinical development), 2006-2012","source_url":"https://people.equilar.com/bio/person/claudia-ordonez-cervomed-inc/30721614","status":"provisional","collected_at":"2026-10-28"}]}},"similar":[{"name":"Fernando Martinez","slug":"fernando-martinez","institution":"University of Massachusetts Chan Medical School","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/fernando-martinez","json_url":"https://www.findmykol.com/kol/fernando-martinez/profile.json"},{"name":"David Gozal","slug":"david-gozal","specialty":"Pediatric Pulmonology","url":"https://www.findmykol.com/kol/david-gozal","json_url":"https://www.findmykol.com/kol/david-gozal/profile.json"},{"name":"Ronald Crystal","slug":"ronald-crystal","institution":"Weill Cornell Medicine","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/ronald-crystal","json_url":"https://www.findmykol.com/kol/ronald-crystal/profile.json"},{"name":"Bartolome Celli","slug":"bartolome-celli","institution":"Brigham and Women's Hospital","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/bartolome-celli","json_url":"https://www.findmykol.com/kol/bartolome-celli/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":1,"funding":18,"publications":25}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-28"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2024 to 2025","collected_at":"2026-10-28"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-28"}},"methodology_url":"https://www.findmykol.com/about#methodology"}